Study Name:
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Targeted Disease(s):
Asthma
Purpose of Study:
If you’ve been living with moderate to severe asthma, you may be eligible to participate in a clinical research study testing a potential new treatment. The purpose of the study is to determine the safety and tolerability of a single dose of the study drug and see how the study drug metabolizes in adult subjects with moderate to severe asthma. The study is evaluating a long-acting investigational medication that targets TSLP — a key driver of airway inflammation in asthma.
Study Dates:
October 1, 2025 - July 30, 2027
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Lead Institution:
Trialmed
Funding Source:
Windward Bio
Contact:
Trialmed Screening Team
877-469-4154
[email protected]
ClinicalTrails.gov Identifier:
NCT07120503
